Japan Digital Pathology Market Size & Outlook, 2023-2030
Japan digital pathology market, 2018-2030 (US$M)
Related Markets
Japan digital pathology market highlights
- The Japan digital pathology market generated a revenue of USD 95.7 million in 2023 and is expected to reach USD 169.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
| Market revenue in 2023 | USD 95.7 million |
| Market revenue in 2030 | USD 169.1 million |
| Growth rate | 8.5% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, Japan accounted for 9.3% of the global digital pathology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan digital pathology market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 62.4 million by 2030.
Device was the largest segment with a revenue share of 52.14% in 2023. Horizon Databook has segmented the Japan digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
Japan held a substantial share of the Asia Pacific digital pathology market over the forecast period attributing to technological developments over the years. For example, as per NCBI, to avoid shortage of technicians fully automated laboratory system that used robotic technology, conveyor and around 72% of National University Hospitals were installed in this region for commercial systemization.
Moreover, approval for novel technologies will further fuel uptake of advance digital pathology platforms fueling market growth. For instance, Royal Philips, one of the key player in the market has received Pharmaceutical and Medical Device Agency (PMDA) approval for its Philips Intelli Site Pathology Solution Japan and in December 2017, the company introduced this device in Japan market. Intelli Site is an automated digital pathology image creating, viewing, and managing system with ultrafast scanner.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan digital pathology market size, by product, 2018-2030 (US$M)
Japan Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
